desoxycorticosterone acetate has been researched along with Bright Disease in 2 studies
Desoxycorticosterone Acetate: The 21-acetate derivative of desoxycorticosterone.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atchison, DK | 1 |
| O'Connor, CL | 1 |
| Menon, R | 1 |
| Otto, EA | 1 |
| Ganesh, SK | 1 |
| Wiggins, RC | 1 |
| Smrcka, AV | 1 |
| Bitzer, M | 1 |
| BOHLE, A | 1 |
| HIERONYMI, G | 1 |
2 other studies available for desoxycorticosterone acetate and Bright Disease
| Article | Year |
|---|---|
Hypertension induces glomerulosclerosis in phospholipase C-ε1 deficiency.
Topics: Albuminuria; Animals; Blood Pressure; Desoxycorticosterone Acetate; Disease Models, Animal; Female; | 2020 |
[Effect of desoxycorticosterone acetate on kidneys and vascular system in rats in Masugi's nephritis].
Topics: Animals; Cardiovascular System; Desoxycorticosterone; Desoxycorticosterone Acetate; Glomerulonephrit | 1953 |